3, 4 Homogenization buffer consisted of 250 mM sucrose in deionized water (Millipore Synergy UV system, 18.2 mΩ/cm, Bedford, MA) adjusted to pH 7.2 with 100 mM sodium hydroxide. Cells were collected in homogenization buffer and centrifuged twice at 1,000g for 10 min. The cell pellet was resuspended in 1 mL homogenization buffer and 1% protease inhibitor cocktail. Cells were lysed with a Dounce homogenizer (clearance, 0.0025 in, Kontes Glass, Vineland, NJ). An organelle pellet was formed from the lysate with sequential 600g (to remove nuclei and cell debris) and 16,100g (to remove cytosol and cytosolic proteins) differential centrifugation steps. The resulting post-nuclear fraction was the control, non-enriched fraction.
To enrich for autophagosomes, mitochondria were first immuno-removed with a Mitochondria
Isolation Kit (MACS, Miltenyi Biotec, Auburn, CA), used according to the manufacturer's procedure and with the homogenization buffer described above. Following mitochondria removal, lysosomes were osmotically lysed with treatment of 500 nM glycyl-Lphenylnapthylamine for 8 min at 37 °C at 200 rpm on a thermomixer. Following treatment, the fraction was centrifuged for 30 min at 16,100g. Western blotting analysis revealed no detectable mitochondria and a highly reduced level of lysosome in the enriched autophagosome fraction (Fig. S5) , consistent with previous published results for rat hepatocyte cells 5 . The resulting organelle pellet was defined as the enriched autophagosome fraction. Protein quantitation was done with the Pierce BCA protein assay kit (Thermo Fisher, Rockford, IL) according to the manufacturer's procedure.
Extractions of Autophagosome Samples
A previously published two step protocol for polar and nonpolar extractions was used for extractions of enriched autophagosome fractions from either rat liver or rat myoblast cell culture which resulted in the %CV of features from experimental replicates being < 30% from organic fractions and being <20% from aqueous extracts 6 . Fractions were treated with 1.5 mL ice cold 1:1 v/v methanol:deionized water. Pellets were resuspended with a syringe, vortexed for 30 s, and incubated for 5 min. Samples were centrifuged at 16,100g for 10 min to pellet any nonextracted materials. The supernatant, defined as the polar extraction, was removed and kept on ice. The remaining pellet was treated with 1.5 mL ice cold 1:3 v/v dichloromethane:methanol.
The pellet was resuspended with a syringe, vortexed for 30 s, and incubated for 5 min. The sample was centrifuged for 16,100g for 10 min to pellet any non-extracted materials. The supernatant, defined as the non-polar extraction, was removed and kept on ice. Extracted samples were vacuum concentrated overnight at room temperature to remove extraction solvent. Sample extracts were stored under nitrogen at -20° C until analysis.
Safety Considerations: All Biosafety Level 2 guidelines were followed when working with cell culture and tissue. Biological waste was bleached for 30 min prior to disposal.
Stimulation of Mast Cells
Murine peritoneal mast cells (MPMCs) were isolated via peritoneal lavage following euthanasia by CO 2 asphyxiation. Lavage was performed using approximately 8 mL per mouse of cell culture media composed of ice-cold high-glucose DMEM supplemented with 10% (v/v) BCS and 1% (v/v) PS, and 6-7 mL lavage fluid were recovered per mouse. After isolation, cells were pelleted at 450xg, resuspended in fresh media, and cultured overnight on a confluent monolayer of NIH/3t3 fibroblasts (purchased from American Type Culture Collection, Manassas, VA) with 0.5 µg/mL anti-TNP IgE.
MPMCs were washed three times with 37 °C Tris buffer (12.5 mM Trizma-HCl, 150 mM NaCl, 4.2 mM KCl, 5.6 mM glucose, 1.5 mM CaCl 2 , and 1.4 mM MgCl 2 , pH 7.4) to remove cell culture media, serum proteins, and cell debris. MPMCs were treated either with Tris buffer (2 cultures prepared) or with Tris buffer containing 200 ng/mL CXCL10 for 2 hr (2 cultures prepared) (Fig S3) . Each pair of cultures was then treated with either Tris buffer or Tris buffer containing 100 ng/mL TNP-ova for 2 hr. These treatments in series created four different activation conditions: (1) Tris buffer followed by Tris buffer, (2) Tris buffer followed by TNPova, (3) CXCL10 followed by Tris buffer, and (4) CXCL10 followed by TNP-ova.
Supernatants were collected and filtered using PTFE 0.2 µm centrifugal filter units at 14,000g for 5 min, then stored overnight at -80 °C. Prior to UPLC/MS e analysis, samples were concentrated to 100 µL, and salts and proteins were precipitated via the addition of 1 mL ice cold ethanol. Samples were then centrifuged at 12,000xg for 10 min, and supernatants were vacuum 3 ESI analysis was performed in positive (+) and negative (-) ionization modes. 4 Overlap of common candidate features detected in a system by OPLS-DA and either LMM or t-test (% CCF). Liver = enriched autophagosomes from liver; myoblast = enriched autophagosomes from rat myoblasts; MCN = mast cells, non-activated; MCTN = TNP-ova-activated mast cells; MCCX = CXCL10-activated mast cells; MCB = Both CXCL10-and TNP-ova-activated. 2 Extractions performed were either nonpolar (NP) or polar (see materials & methods). NA = no extraction made. The "+" or "-" sign indicates that ESI analysis was performed in positive (+) and negative (-) ionization modes. 3 Observed m/z values (m/z column) was used to determine the neutral mass (Neutral mass column). 4 T R is the observed retention time (min). 5 Chemometrics/statistics that led to selection of a given feature were: OPLS-DA = Orthogonal partial least squares with discriminate analysis, LMM = Linear mixed model, or tTest. The p-values correspond to significance determined with either LMM or t-test. N.A. = Not applicable. 6 FE = Fold enrichment. N.D. = Not determined. 7 Preliminary identifications were based on the following databases: CE = Chemical Entities of Biological Interest, HM = Human Metabolome Database, LP = Lipid Maps, and CS = Chemspider. "All" indicates that the compound was found in all four databases. 8 Comparison of the ID Mass and the Neutral mass column was used to determine the error mass in mDa or ppm. samples; (E) Low-collision energy mass spectrum at T R = 13.11 min; (F) High-collision energy mass spectrum at T R = 13.11 min; (G) Elemental compositions, m/z values, and mass error of observed fragment ion corresponding to theoretical fragment ions generated in silico using Mass Fragment!.
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Fig. S7
Examples of structures of preliminary identifications made for (A) rat liver autophagosomes, (B) rat myoblast autophagosomes, and (C) stimulant-activated mast cells. Two structural isomers of compound HMDB00269 (*) were detected in enriched rat liver autophagosomes (see Table 1 ). 
